stocks
GENPHARMA

Genpharmasec Ltd.

1.07+0.0 (+0.94%)
7 Aug, 12:00 AM

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap
59.25
P/E (TTM)
105.78
P/B
0.89
P/S (TTM)
0.42
EV/EBITDA
68.03
CAPE (5Y)
111.46
ROE (TTM)
0.85
ROCE (TTM)
-1.12
ROA (TTM)
0.51
Avg 3Y ROE
0.81
Earnings 3Y CAGR
-25.72
Sales 3Y CAGR
76.35
Sales 5Y CAGR
45.71
Debt/Equity
0.53
Consensus TP
-
Strong Buy %
-
Promoter Holding
29.98
Pledged %
0.00

Share Price

Track Genpharmasec Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: 2.88 %
Low
1.0
High
1.1
1 Month returns: -0.93 %
Low
1.0
High
1.1
1 Year returns: -45.69 %
Low
0.8
High
2.2
3 Year CAGR: -19.09 %
Low
0.8
High
7.3
5 Year CAGR: -29.13 %
Low
0.8
High
7.3
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Genpharmasec Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Genpharmasec Ltd. Shareholding Pattern

Quarterly breakdown of Genpharmasec Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Genpharmasec Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Genpharmasec Ltd.?
The current share price of Genpharmasec Ltd. is ₹ 1.07 as of 7 Aug 2026.
What is the market capitalisation of Genpharmasec Ltd.?
The market capitalisation of Genpharmasec Ltd. stands at ₹ 59.25 Cr.
What is the PE ratio of Genpharmasec Ltd.?
The Price-to-Earnings (PE) ratio of Genpharmasec Ltd. is 105.78 as of the latest trailing twelve months data.
What is the ROE and ROCE of Genpharmasec Ltd.?
Genpharmasec Ltd. has a Return on Equity (ROE) of 0.85% and a Return on Capital Employed (ROCE) of -1.12% as per the latest financial reports.
What is the 52-week high and low of Genpharmasec Ltd.?
The 52-week high of Genpharmasec Ltd. is - and the 52-week low is -.
What is the dividend yield of Genpharmasec Ltd.?
The dividend yield of Genpharmasec Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Genpharmasec Ltd.?
Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 68.20% of Genpharmasec Ltd. shares.
What sector does Genpharmasec Ltd. belong to?
Genpharmasec Ltd. operates in the Services sector.
What is the beta of Genpharmasec Ltd.?
The beta of Genpharmasec Ltd. is 1.16, indicating its price volatility relative to the broader market. Over the past 1 year, Genpharmasec Ltd. has delivered an absolute return of -46.23%.
What is the RSI of Genpharmasec Ltd.?
The 14-day Relative Strength Index (RSI) of Genpharmasec Ltd. is 51.59, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.